FDA Adverse Event Malfunction Summary report: N

TPW 24IN 2-0 D/A SH,SKS-3 BWY

MDR report key: 12139930 · Received July 8, 2021

Report

Report Number
2210968-2021-06134
Event Type
Malfunction
Date Received
July 8, 2021
Date of Event
June 23, 2021
Report Date
June 29, 2021
Manufacturer
ETHICON INC.
Product Code
LDF
UDI-DI
10705031050884
PMA / PMN Number
K980503
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

PRODUCT COMPLAINT # (B)(4). DATE SENT TO THE FDA: 9/09/2021. THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ETHICON INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ETHICON INC OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. H6 COMPONENT CODE: G07002 DEVICE NOT RETURNED. ADDITIONAL INFORMATION WAS REQUESTED, AND THE FOLLOWING WAS OBTAINED: THE PATIENT DEMOGRAPHIC INFO: WEIGHT, BMI AT THE TIME OF INDEX PROCEDURE? THE PATIENT¿S INITIALS ARE YH. 68 YEARS OLD FEMALE. DID THE OPERATING SURGEON OBSERVE ANY PRODUCT DEFICIENCY OR ANOMALY BEFORE, DURING OR AFTER THE PLACEMENT? NO FURTHER INFORMATION IS AVAILABLE. OTHER RELEVANT PATIENT COMORBIDITIES/PATIENT FACTORS/CONCOMITANT MEDICATIONS? NO FURTHER INFORMATION IS AVAILABLE. WERE THERE ANY ADVERSE PATIENT CONSEQUENCES/SYMPTOMS DUE TO TEMPORARY PACING WIRE BREAKAGE POST-OP OCCURRED? NO FURTHER INFORMATION IS AVAILABLE. WAS THERE ANY MEDICAL/SURGICAL INTERVENTION REQUIRED DUE TO TEMPORARY PACING WIRE BREAKAGE POST-OP? NO FURTHER INFORMATION IS AVAILABLE. WHAT IS PHYSICIAN¿S OPINION AS TO THE ETIOLOGY OF OR CONTRIBUTING FACTORS TO THIS EVENT (TEMPORARY PACING WIRE RUPTURE/BREAKAGE)? THE DOCTOR COMMENTED THAT THE CAUSAL RELATIONSHIP WITH THE DEATH WAS COMPLETELY UNRELATED. THE REASON WAS THAT ALL PACING WAS PERFORMED WITH VVI AND THE RATE WAS 90. EVEN IF THE PACING WIRE IS TORN, THE RATE IS ABOUT 60, WHICH DOES NOT MEAN THAT THE RATE HAS DECREASED EXTREMELY. PRODUCT LOT NUMBER? NO FURTHER INFORMATION IS AVAILABLE. IS THE ACTUAL PRODUCT INVOLVED IN THE REPORTED ISSUE AND USED IN THE SURGICAL PROCEDURE BEING RETURNED FOR ANALYSIS? NO SAMPLE WILL BE RETURNED. WHAT WAS A CAUSE OF PATIENT¿S DEATH ON (B)(6) 2021? NO FURTHER INFORMATION IS AVAILABLE. NO FURTHER INFORMATION WILL BE PROVIDED.

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT (B)(4). (B)(4). TO DATE THE DEVICE HAS NOT BEEN RETURNED. IF THE DEVICE OR FURTHER DETAILS ARE RECEIVED AT THE LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. ATTEMPTS ARE BEING MADE TO CLARIFY THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. THE PATIENT DEMOGRAPHIC INFO: WEIGHT, BMI AT THE TIME OF INDEX PROCEDURE? DID THE OPERATING SURGEON OBSERVE ANY PRODUCT DEFICIENCY OR ANOMALY BEFORE, DURING OR AFTER THE PLACEMENT? OTHER RELEVANT PATIENT COMORBIDITIES/PATIENT FACTORS/CONCOMITANT MEDICATIONS? WERE THERE ANY ADVERSE PATIENT CONSEQUENCES/SYMPTOMS DUE TO TEMPORARY PACING WIRE BREAKAGE POST-OP OCCURRED? WAS THERE ANY MEDICAL/SURGICAL INTERVENTION REQUIRED DUE TO TEMPORARY PACING WIRE BREAKAGE POST-OP? WHAT IS PHYSICIANS OPINION AS TO THE ETIOLOGY OF OR CONTRIBUTING FACTORS TO THIS EVENT (TEMPORARY PACING WIRE RUPTURE/BREAKAGE)? PRODUCT LOT NUMBER? IS THE ACTUAL PRODUCT INVOLVED IN THE REPORTED ISSUE AND USED IN THE SURGICAL PROCEDURE BEING RETURNED FOR ANALYSIS? WHAT WAS A CAUSE OF PATIENTS DEATH ON (B)(6) 2021?

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT IN A VERY SEVERE CONDITION UNDERWENT A BENTALL SURGERY ON (B)(6) 2021 AND THE TEMPORARY PACING WIRE WAS PLACED OVER THE RA/ATRIUM AND RV/VENTRICLE AND CONNECTED TO THE GENERATOR FOR PACING. THE POSTOPERATIVE CONDITION WAS POOR, AND IT BECAME LONG-TERM PACING MANAGEMENT. ON (B)(6) 2021, AFTER AN X-RAY, A RUPTURE OCCURRED AT THE CONNECTION PART BETWEEN THE PACING WIRE AND STRAIGHT NEEDLE THAT WAS CONNECTED TO THE GENERATOR. THERE WAS TIME WHEN PACING COULD NOT BE PERFORMED TEMPORARILY DUE TO RUPTURE AND A SURGEON PEELED OFF THE POLYETHYLENE COATING AND RECONNECTED TO THE GENERATOR. IT WAS ALSO REPORTED THAT THE PATIENT SUBSEQUENTLY DIED ON (B)(6) 2021. THE DOCTOR COMMENTED THAT THE CAUSAL RELATIONSHIP BETWEEN PRODUCT/EVENT WITH THE DEATH WAS COMPLETELY UNRELATED. THE REASON WAS THAT ALL PACING WAS PERFORMED WITH PERMANENT PACEMAKER VVI AND THE RATE WAS 90. EVEN IF THE TEMPORARY PACING WIRE WAS TORN, THE RATE WAS ABOUT 60, WHICH DOES NOT MEAN THAT THE RATE HAS DECREASED EXTREMELY. ALSO OTHER CONTRIBUTED FACTOR WAS THAT THE PATIENT WAS ORIGINALLY IN A VERY SEVERE CONDITION. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1033478 TPW 24IN 2-0 D/A SH,SKS-3 BWY ELECTRODE, PACEMAKER, TEMP LDF ETHICON INC. TPW30 10705031050884

Patients

Seq Age Sex Outcome Treatment
1 68 YR